bf/NASDAQ:MRNS_icon.jpeg

NASDAQ:MRNS

Marinus Pharmaceuticals, Inc.

  • Stock

USD

Last Close

8.85

28/03 17:28

Market Cap

546.83M

Beta: 1.16

Volume Today

171.94K

Avg: 544.92K

PE Ratio

−4.02

PFCF: −4.81

  • industry

    Biotechnology
  • exchange

    NASDAQ Global Market
  • website

    marinuspharma.com
  • ipo date

    Jul 31, 2014
  • full time employees

    151
  • currency

    USD

Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of products for patients suffering from rare genetic epilepsies and other seizure disorders. It offers ZTALMY, an oral suspension for the treatment of seizures associated with cyclin-dependent kinas...Show More

Earnings

Earnings per Share (Estimate*)

-2-1.5-1-0.52015-03-122017-03-132019-03-112021-03-092023-03-07

Revenue (Estimate*)

5M10M15M20M2015-03-122017-03-132019-03-112021-03-092023-03-07

*Estimate based on analyst consensus

Please Sign In To Use The Chat

The chat is only available for registered users, please sign in or create your free account.